Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology
Background: Emerging evidence demonstrates that bone is an endocrine organ capable of influencing multiple physiological and pathological processes through the secretion of hormones. Recent research suggests complex crosstalk between the bone and other metabolic and cardiovascular tissues. It was un...
Saved in:
Main Authors: | Xuzhu Lin (Author), Danise-Ann Onda (Author), Chieh-Hsin Yang (Author), Joshua R. Lewis (Author), Itamar Levinger (Author), Kim Loh (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
by: Chieh-Hsin Yang, et al.
Published: (2022) -
Adrenocorticotropic hormone at pathophysiological concentration modulates the proliferation and differentiation of bone cells
by: Tsuyoshi Sato, et al.
Published: (2015) -
Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
by: Man K.S. Lee, et al.
Published: (2022) -
Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness
by: Taejin Kim, et al.
Published: (2023) -
Cardiovascular Pathophysiology for Pre-Clinical Students
by: Binks, Andrew
Published: (2022)